Guanze Medical Information Industry (HKG:2427) recorded an attributable loss of 29.7 million yuan in 2025, compared with an attributable profit of 17.2 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.
Shares of the medical imaging film products maker slipped nearly 3% Wednesday afternoon trading.
Loss per share stood at 0.03 yuan, compared with 0.02 yuan in the corresponding period of the last fiscal year.
Revenue slid 43% to 88.4 million yuan from 155.7 million yuan in the year-ago period, mainly due to lower sales of medical imaging film products and cloud services.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments